Skip to main content
Clinical Trials/NCT01180192
NCT01180192
Unknown
Phase 4

Phase 3 Study of Postpartum Oxygen Inhalation for the Treatment of Postpartum Haemorrhage

Erzincan Military Hospital1 site in 1 country450 target enrollmentMay 2010
Interventionsoxygen
Drugsoxygen

Overview

Phase
Phase 4
Intervention
oxygen
Conditions
Postpartum Hemorrhage
Sponsor
Erzincan Military Hospital
Enrollment
450
Locations
1
Primary Endpoint
The primary outcome was the amount of blood loss in the third and fourth stages of labor.
Last Updated
15 years ago

Overview

Brief Summary

In the aetiology of postpartum uterine atony, hypoxia is considered an important factor although some suggest that peripheral oxygen saturation is not influenced by oxygen inhalation in women during the first and second stages of labor. Enhancing oxygen delivery to myometrium through additional inhaled oxygen may improve uterine contractions. Therefore, it is reasonable to consider that oxygen inhalation may promote myometrial contraction and prevent postpartum haemorrhage (PPH) due to uterine atony. The tendency for the uterus to relax in women encountering respiratory problems immediately after cesarean section under general anaesthesia further strengthened this theory.

The aim of this study was to evaluate the effectiveness of oxygen inhalation immediately after vaginal delivery on blood loss. The investigators hypothesized that inhaled oxygen helps to maintain uterine retraction during immediate postpartum period and hence reduces vaginal blood loss.

Registry
clinicaltrials.gov
Start Date
May 2010
End Date
September 2010
Last Updated
15 years ago
Study Type
Interventional
Study Design
Crossover
Sex
Female

Investigators

Sponsor
Erzincan Military Hospital

Eligibility Criteria

Inclusion Criteria

  • gestational age between 37 and 42 weeks;
  • singleton pregnancy;
  • live fetus;
  • cephalic presentation;
  • neonatal birth weight of 2500-4500 g;
  • parity between one and five;
  • maternal age \< 35 years old;
  • vaginal birth

Exclusion Criteria

  • blood pressure ≥ 140/90mmHg;
  • placenta previa;
  • placental abruption;
  • a history of any bleeding during pregnancy;
  • a history of curettage;
  • cesarean section or any uterine scar;
  • a history of postpartum hemorrhage;
  • polyhydramnios;
  • signs or symptoms of maternal infection;
  • known uterine anomalies;

Arms & Interventions

oxygen

Intervention: oxygen

Outcomes

Primary Outcomes

The primary outcome was the amount of blood loss in the third and fourth stages of labor.

Time Frame: two hours

The volume of blood loss was measured by weighing a sheet soaked from the end of the delivery to 2h after birth. Because it is important to collect the blood accurately, we used a specially designed operating sheet and an electronic scale to weigh all the material (with a 1 g deviation range). The quantity of blood (ml) = (weight of used materials - weight of materials prior to use)/1.05. Hemoglobin concentration was estimated on admission and 24 h after delivery

Secondary Outcomes

  • incidences of Postpartum Haemorrhage (PPH) (≥500 ml)(two hours)

Study Sites (1)

Loading locations...

Similar Trials